• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟代亚氨基糖醇:一类新型糖苷酶抑制剂和药理学伴侣分子。

Fluorous iminoalditols: a new family of glycosidase inhibitors and pharmacological chaperones.

机构信息

Glycogroup, Deparment of Organic Chemistry, Graz University of Technology, 8010 Graz, Austria.

出版信息

Chembiochem. 2010 Sep 24;11(14):2026-33. doi: 10.1002/cbic.201000192.

DOI:10.1002/cbic.201000192
PMID:20715263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3198847/
Abstract

A collection of new reversible glycosidase inhibitors of the iminoalditol type featuring N-substituents containing perfluorinated regions has been prepared for evaluation of physicochemical, biochemical and diagnostic properties. The vast variety of feasible oligofluoro moieties allows for modular approaches to customised structures according to the intended applications, which are influenced by the fluorine content as well as the distance of the fluorous moiety from the ring nitrogen. The first examples, in particular in the D-galacto series, exhibited excellent inhibitory activities. A preliminary screen with two human cell lines showed that, at subinhibitory concentrations, they are powerful pharmacological chaperones enhancing the activities of the catalytically handicapped lysosomal D-galactosidase mutants associated with GM1 gangliosidosis and Morquio B disease.

摘要

已经制备了一系列新型的、含有全氟区域的亚氨基糖醇型可逆糖苷酶抑制剂,用于评估物理化学、生化和诊断特性。大量可行的低氟部分允许根据预期应用进行定制结构的模块化方法,这受到氟含量以及氟部分与环氮之间距离的影响。特别是在 D-半乳糖系列中的第一个实例,表现出优异的抑制活性。对两种人类细胞系的初步筛选表明,在亚抑制浓度下,它们是强大的药理学伴侣,可增强与 GM1 神经节苷脂病和 Morquio B 病相关的催化功能障碍溶酶体 D-半乳糖苷酶突变体的活性。

相似文献

1
Fluorous iminoalditols: a new family of glycosidase inhibitors and pharmacological chaperones.氟代亚氨基糖醇:一类新型糖苷酶抑制剂和药理学伴侣分子。
Chembiochem. 2010 Sep 24;11(14):2026-33. doi: 10.1002/cbic.201000192.
2
Fluorous iminoalditols act as effective pharmacological chaperones against gene products from GLB₁ alleles causing GM1-gangliosidosis and Morquio B disease.氟代亚氨基糖醇类化合物作为有效的药理学伴侣,可针对导致 GM1 神经节苷脂贮积症和莫尔奎氏 B 型疾病的 GLB1 等位基因产物发挥作用。
J Inherit Metab Dis. 2012 May;35(3):495-503. doi: 10.1007/s10545-011-9409-2. Epub 2011 Oct 28.
3
5-Fluoro derivatives of 4-epi-isofagomine as D-galactosidase inhibitors and potential pharmacological chaperones for GM1-gangliosidosis as well as Fabry's disease.4-表异麦角胺的5-氟衍生物作为D-半乳糖苷酶抑制剂以及用于GM1神经节苷脂贮积症和法布里病的潜在药理伴侣。
Carbohydr Res. 2016 Feb;420:6-12. doi: 10.1016/j.carres.2015.10.009. Epub 2015 Dec 8.
4
Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and -5a-Substituted Derivatives of 4--Isofagomine.人溶酶体半乳糖苷酶活性的伴侣机制研究:高度官能化的氨基环戊烷和 4--异野尻霉素的 -5a-取代衍生物。
Molecules. 2020 Sep 3;25(17):4025. doi: 10.3390/molecules25174025.
5
1-Deoxy-D-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines.1-脱氧-D-半乳糖壬吡喃糖霉素衍生物,带有丹磺酰封端的 N-取代基,作为β-半乳糖苷酶抑制剂和用于 GM1 神经节苷脂贮积病细胞系的潜在探针。
Carbohydr Res. 2011 Sep 6;346(12):1592-8. doi: 10.1016/j.carres.2011.05.010. Epub 2011 May 24.
6
Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis.通过糖苷酶抑制剂的非糖部分相互作用进行调节:法布雷病和神经节苷脂贮积症的药理学伴侣分子。
Chem Commun (Camb). 2012 Jul 4;48(52):6514-6. doi: 10.1039/c2cc32065g. Epub 2012 May 23.
7
4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations.4-表异石蒜堿衍生物作为治疗与β-半乳糖苷酶突变相关的溶酶体疾病的药理学伴侣:改进的合成和生物学研究。
Bioorg Med Chem. 2018 Nov 1;26(20):5462-5469. doi: 10.1016/j.bmc.2018.09.023. Epub 2018 Sep 21.
8
A new type of pharmacological chaperone for G-gangliosidosis related human lysosomal β-galactosidase: N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols.一种用于治疗G-神经节苷脂沉积症相关人类溶酶体β-半乳糖苷酶的新型药理伴侣:N-取代的5-氨基-1-羟甲基环戊三醇。
Bioorg Med Chem Lett. 2017 Aug 1;27(15):3431-3435. doi: 10.1016/j.bmcl.2017.05.086. Epub 2017 May 30.
9
(5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.(5aR)-5a-C-戊基-4-表异法戈明:一种强大的溶酶体β-半乳糖苷酶抑制剂,也是与GM1神经节苷脂贮积症和B型莫尔基奥氏病相关突变的显著伴侣分子。
Eur J Med Chem. 2017 Jan 27;126:160-170. doi: 10.1016/j.ejmech.2016.09.095. Epub 2016 Sep 29.
10
N-Alkyl-, 1-C-Alkyl-, and 5-C-Alkyl-1,5-dideoxy-1,5-imino-(L)-ribitols as Galactosidase Inhibitors.作为半乳糖苷酶抑制剂的N-烷基-、1-C-烷基-和5-C-烷基-1,5-二脱氧-1,5-亚氨基-(L)-核糖醇
ChemMedChem. 2016 Jan 5;11(1):133-41. doi: 10.1002/cmdc.201500485. Epub 2015 Dec 8.

引用本文的文献

1
-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-Glucocerebrosidase.基于烷基化脒基糖的配体:人溶酶体β-葡萄糖脑苷脂酶的合成与抑制。
Molecules. 2020 Oct 11;25(20):4618. doi: 10.3390/molecules25204618.
2
Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and -5a-Substituted Derivatives of 4--Isofagomine.人溶酶体半乳糖苷酶活性的伴侣机制研究:高度官能化的氨基环戊烷和 4--异野尻霉素的 -5a-取代衍生物。
Molecules. 2020 Sep 3;25(17):4025. doi: 10.3390/molecules25174025.
3
Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones.调节溶酶体贮积症中的蛋白质折叠:药理伴侣背后的化学原理。
Chem Sci. 2018 Jan 10;9(7):1740-1752. doi: 10.1039/c7sc04712f. eCollection 2018 Feb 21.
4
A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.一种双环 1-脱氧半乳糖基氮杂环庚烷衍生物,作为 GM1 神经节苷脂贮积症的新型药理学伴侣。
Mol Ther. 2013 Mar;21(3):526-32. doi: 10.1038/mt.2012.263. Epub 2013 Jan 22.
5
Fluorous iminoalditols act as effective pharmacological chaperones against gene products from GLB₁ alleles causing GM1-gangliosidosis and Morquio B disease.氟代亚氨基糖醇类化合物作为有效的药理学伴侣,可针对导致 GM1 神经节苷脂贮积症和莫尔奎氏 B 型疾病的 GLB1 等位基因产物发挥作用。
J Inherit Metab Dis. 2012 May;35(3):495-503. doi: 10.1007/s10545-011-9409-2. Epub 2011 Oct 28.
6
Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders.鉴定和表征用于纠正溶酶体贮积症中酶缺陷的药理学伴侣分子。
Assay Drug Dev Technol. 2011 Jun;9(3):213-35. doi: 10.1089/adt.2011.0370.

本文引用的文献

1
2-Acetamino-1,2-dideoxynojirimycin-lysine hybrids as hexosaminidase inhibitors.作为己糖胺酶抑制剂的2-乙酰氨基-1,2-二脱氧野尻霉素-赖氨酸杂合物
Tetrahedron Asymmetry. 2009 May 1;20(6-8):832-835. doi: 10.1016/j.tetasy.2009.02.015.
2
Fluorous-based small-molecule microarrays for protein, antibody and enzyme screening.基于氟的小分子微阵列用于蛋白质、抗体和酶的筛选。
Future Med Chem. 2009 Aug;1(5):889-96. doi: 10.4155/fmc.09.76.
3
Fluorous-based Peptide Microarrays for Protease Screening.用于蛋白酶筛选的基于氟的肽微阵列
J Fluor Chem. 2009 Nov 1;130(11):1042-1048. doi: 10.1016/j.jfluchem.2009.09.005.
4
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.药物伴侣依发麦明能提高 Gaucher 病 L444P 突变β-葡萄糖苷酶的活性。
FEBS J. 2010 Apr;277(7):1618-38. doi: 10.1111/j.1742-4658.2010.07588.x. Epub 2010 Feb 10.
5
A highly active DNA polymerase with a fluorous core.一种具有氟代核心的高活性DNA聚合酶。
Angew Chem Int Ed Engl. 2010 Feb 8;49(7):1324-7. doi: 10.1002/anie.200905978.
6
Engineering protein stability and specificity using fluorous amino acids: the importance of packing effects.利用含氟氨基酸工程化改造蛋白质稳定性和特异性:堆积效应的重要性
Biochemistry. 2009 Nov 17;48(45):10810-7. doi: 10.1021/bi901481k.
7
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.针对神经元病变型溶酶体疾病的伴侣蛋白疗法:竞争性抑制剂作为化学伴侣蛋白以增强突变酶活性。
Perspect Medicin Chem. 2009 May 26;3:7-19. doi: 10.4137/pmc.s2332.
8
Fluorous Chemistry in Pittsburgh: 1996-2008.匹兹堡的氟化学:1996 - 2008年
J Fluor Chem. 2008 Oct;129(10):898-902. doi: 10.1016/j.jfluchem.2008.05.025.
9
Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.氨溴索作为戈谢病酶增强剂的鉴定与表征
J Biol Chem. 2009 Aug 28;284(35):23502-16. doi: 10.1074/jbc.M109.012393. Epub 2009 Jul 3.
10
GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase.GM1神经节苷脂贮积症和莫尔基奥B病:影响酸性β-半乳糖苷酶催化位点的错义突变的表达分析
Hum Mutat. 2009 Aug;30(8):1214-21. doi: 10.1002/humu.21031.